Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001493152-19-013715
Filing Date
2019-09-05
Accepted
2019-09-05 09:46:35
Documents
2
Effectiveness Date
2019-09-05

Document Format Files

Seq Description Document Type Size
1 defr14-a.htm DEFR14A 181079
2 image_001.jpg GRAPHIC 840
  Complete submission text file 0001493152-19-013715.txt   183473
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-54933 | Film No.: 191076328
SIC: 2834 Pharmaceutical Preparations